Hutch News

Hutch News

Stories tagged 'David G Maloney'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 13, 2016

Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response.

View story >


Patients with advanced lymphoma in remission after T-cell therapy

New study: 7 of 11 trial participants who got two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission

Sept. 7, 2016 | By Susan Keown / Fred Hutch News Service

Seven of 11 trial participants who got a two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission, a new study found.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 24, 2016

View story >


Hutch News

Stories include: pregnancy and cancer diagnosis, new strides in metastatic breast cancer research, incredible remission rates after immunotherapy and more

June 15, 2016

Recent stories from Fred Hutch News Service include pregnancy and cancer diagnosis, new strides in metastatic breast cancer research, incredible remission rates after immunotherapy and more.

View story >


93 percent of advanced leukemia patients in remission after immunotherapy

‘Exciting’ but early results from trial of engineered immune cells

April 25, 2016 | By Susan Keown / Fred Hutch News Service

After her immune cells were genetically engineered to target her cancer, Kristin Kleinhofer's leukemia disappeared. The trial was her and her family's 'last hope'.

View story >


Dramatic remissions seen in immunotherapy trial of blood cancer patients

Experimental, living T-cell therapy shows promise for treating advanced disease, making immunotherapy a ‘pillar’ of cancer care

Feb. 16, 2016 | By Andrea Detter / Fred Hutch News Service

Many patients with advanced blood cancers who are receiving experimental, “living” immunotherapy as part of a clinical trial are experiencing sustained remissions, according to preliminary results of the ongoing study at Fred Hutchinson Cancer Research Center.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.